Cargando…

The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro

Several lines of evidence show that de novo expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is strongly associated with reduced disease-free survival of patients affected by metastatic melanoma. Previously published investigations report that homophilic interactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dupuis, Maria L., Fiori, Valentina, Soriani, Alessandra, Ricci, Biancamaria, Dominici, Sabrina, Moricoli, Diego, Ascione, Alessandro, Santoni, Angela, Magnani, Mauro, Cianfriglia, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Basic Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605278/ https://www.ncbi.nlm.nih.gov/pubmed/26448580 http://dx.doi.org/10.1097/CJI.0000000000000100

Ejemplares similares

EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
por: Park, Dong Jun, et al.
Publicado: (2020)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
por: Suda, Takahiro, et al.
Publicado: (2018)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells
por: Flego, Michela, et al.
Publicado: (2007)

Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections
por: Bächle, Susanna M., et al.
Publicado: (2016)

Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
por: Soriani, Alessandra, et al.
Publicado: (2013)

Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis
por: Zhang, Hui, et al.
Publicado: (2013)

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
por: Fionda, Cinzia, et al.
Publicado: (2015)

Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
por: Klaile, Esther, et al.
Publicado: (2017)

Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
por: Zingoni, Alessandra, et al.
Publicado: (2017)

Regulation of CEACAM1 transcription in human breast epithelial cells
por: Gencheva, Marieta, et al.
Publicado: (2010)

Effect of CEACAM-1 knockdown in human colorectal cancer cells
por: Han, Zhong-Min, et al.
Publicado: (2018)

Activation of natural killer T cells contributes to Th1 bias in the murine liver after 14 d of ethinylestradiol exposure
por: Zou, Meng-Zhi, et al.
Publicado: (2022)

Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells
por: Kim, Yeon Ji, et al.
Publicado: (2021)

Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src
por: Müller, Mario M., et al.
Publicado: (2009)

Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses
por: Singer, Bernhard B., et al.
Publicado: (2014)

IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells
por: Landolina, Nadine, et al.
Publicado: (2022)

Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1
por: Iijima, Hideki, et al.
Publicado: (2004)

Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach
por: Flego, Michela, et al.
Publicado: (2005)

Reversal of obesity development in Ceacam1 ( −/− ) male mice by bone marrow transplantation or introduction of the human CEACAM1 gene
por: Zhang, Zhifang, et al.
Publicado: (2022)

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
por: Chen, Heyu, et al.
Publicado: (2020)

4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
por: Schmit, Megan, et al.
Publicado: (2020)

CEACAM1 Promotes Melanoma Cell Growth through Sox-2()()
por: Ortenberg, Rona, et al.
Publicado: (2014)

Inhibition of cell invasion and migration by CEACAM1-4S in breast cancer
por: Yang, Changcheng, et al.
Publicado: (2017)

CEACAM1: Expression and Role in Melanocyte Transformation
por: Turcu, Gabriela, et al.
Publicado: (2016)

CEACAM1-Mediated Inhibition of Virus Production
por: Vitenshtein, Alon, et al.
Publicado: (2016)

CEACAM1 promotes vascular aging processes
por: Kleefeldt, Florian, et al.
Publicado: (2020)

Structural analysis of human CEACAM1 oligomerization
por: Gandhi, Amit K., et al.
Publicado: (2022)

Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
por: Han, Qiu-Ju, et al.
Publicado: (2021)

The CEACAM1 N-terminal Ig domain mediates cis- and trans-binding and is essential for allosteric rearrangements of CEACAM1 microclusters
por: Klaile, Esther, et al.
Publicado: (2009)

Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene
por: Russo, Lucia, et al.
Publicado: (2018)

Characterization of murine CEACAM1 in vivo reveals low expression on CD8(+) T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1
por: McLeod, Robbie L., et al.
Publicado: (2018)

HIV-1 induced changes in HLA-C∗03 : 04-presented peptide repertoires lead to reduced engagement of inhibitory natural killer cell receptors
por: Ziegler, Maja C., et al.
Publicado: (2020)

Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease
por: Lord, James D, et al.
Publicado: (2017)

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
por: Flego, Michela, et al.
Publicado: (2013)

Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from Yeast
por: Mallano, Alessandra, et al.
Publicado: (2008)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
por: Rovituso, Damiano M., et al.
Publicado: (2016)

SAT-174 Loss of CEACAM1 in Endothelial Cells Causes Hepatic Fibrogenesis
por: Muturi, Harrison, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s71scuuid17675jse1pb8afmo5